Developer docs
API playgroundTry for free, no card

Search company profiles

Cerebriu

Full company profile

uuid0002q88

Namestring
Cerebriu
Legal namestring
Cerebriu A/S
Websiteurl
cerebriu.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Cerebriu is a Danish health technology company founded in 2018 that develops Apollo, a CE-marked AI software suite designed to automate brain MRI workflows from image acquisition through diagnosis. The platform comprises three integrated modules: Smart Priority (real-time scan monitoring that flags critical findings such as infarcts, hemorrhages, and tumors as they emerge during acquisition), Smart Protocol (real-time protocol adaptation that suggests or applies sequence modifications while the patient remains on the scanner table), and Smart Reading (AI-driven worklist prioritization and triage across multiple scanners and facilities). Cerebriu's AI was trained on multi-hospital datasets and validated in a 995-patient European Journal of Radiology study demonstrating 89% sensitivity and 90% specificity for acute ischemic lesion detection.

Apollo is regulated as a medical device in the EU under MDR 2017/745 Article 120 and achieved the first-ever CE-mark for embedded clinical AI integrated into MRI scanner consoles through a flagship OEM partnership with Siemens Healthineers via the SHS Open Workflow. The company runs its inference on Oracle Cloud Infrastructure GPU clusters, including NVIDIA GB200 NVL72 systems. Customers span hospitals, radiology centers, stroke centers, and teleradiology providers across Europe, Asia, the Middle East, and the US (clinical validation), including Copenhagen University Hospital, Oslo University Hospital, Clalit Health Services, Soroka Medical Center, Guy's and St Thomas' NHS Foundation Trust, UMC Utrecht, and Assuta Medical Centers.

Cerebriu monetizes through three revenue streams: OEM software licensing to MRI manufacturers (notably Siemens Healthineers), subscription-based access via AI platform partners (deepcOS, CARPL.ai), and direct enterprise sales through Regional Sales Managers covering EMEA and APAC territories. Distribution partnerships include HCKonnect for Switzerland and North Africa, and a co-development partnership with Vista.ai for automated MR acquisition. Total funding raised is approximately €26.8 million across a Eurostars grant (2021), a $19M Series A led by North Ventures (September 2024), and a €9.4M strategic financing round (August 2025). FDA clearance is in progress.

Short descriptiontext

Cerebriu is a Danish health tech company developing Apollo, a CE-marked AI software suite for brain MRI workflow automation. It serves hospitals, radiology centers, and stroke centers across EMEA and APAC through OEM partnerships (Siemens Healthineers), AI platform distribution, and direct enterprise sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCopenhagen, Denmark
HQ citystring
Copenhagen
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI medical imaging, brain MRI workflow, radiology AI software, MRI protocol optimization, medical imaging analytics
Industry2 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1OEM Software Licensing
TypeLicensing Royalties
Description

Cerebriu licenses its Apollo Software Suite to OEM partners like Siemens Healthineers for integration into MRI scanner consoles. The software is embedded at point of manufacture, generating recurring licensing revenue from OEM deployment.

cerebriu.com
2Platform Subscription
TypeSubscription Recurring
Description

AI platform and distributor partnerships (deepc, CARPL.ai) provide subscription-based access to Apollo modules. Healthcare providers access Smart Reading and other features through integrated platforms, creating recurring SaaS-type revenue.

cerebriu.com
3Direct Enterprise Sales
TypeSubscription Recurring
Description

Direct B2B sales of Apollo platform to hospitals, diagnostic groups, and imaging networks. Sales cycles involve clinical and executive stakeholder engagement with Regional Sales Managers covering EMEA and APAC territories.

cerebriu.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Enterprise pricing based on deployment scope
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing negotiated at enterprise level. Pricing varies based on number of MRI scanners, deployment type (OEM-embedded vs standalone), integration requirements, and geographic scope.

cerebriu.com
2OEM/Embedded deployment pricing
ModelLicensing/ royaltiesBilling cadenceMulti-year contract
Notes

Licensing fees for OEM integration with MRI manufacturers like Siemens Healthineers, with pricing structured based on scanner volume and deployment scope.

cerebriu.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Apollo
Description

AI-based Software Suite for brain MRI workflow optimization providing real-time alerts on critical conditions, on-table detection of critical findings for prioritized reading, and real-time adaptation of MR scanning protocols.

cerebriu.com
Core offering1 text field

Cerebriu develops Apollo, a CE-marked AI-powered Software Suite for brain MRI workflows. Apollo operates at the point of imaging to optimize the end-to-end brain MRI pathway from acquisition to diagnosis through three integrated modules: Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation while patient remains on scanner), and Smart Reading (AI-driven worklist prioritization and triage). The suite is sold to hospitals, radiology centers, and OEMs, including a dedicated OEM-embedded variant integrated into Siemens Healthineers MRI consoles.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 89% sensitivity and 90% specificity for acute ischemic lesion detection on brain MRI
+4 more records
Product overview1 text field

Cerebriu offers Apollo, an AI-powered Software Suite for brain MRI workflows. Apollo is a modular platform comprising three core AI modules — Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation), and Smart Reading (AI-driven worklist prioritization and triage) — that collectively automate the end-to-end brain MRI pathway from image acquisition through diagnosis. Apollo is regulated as a medical device in the EU (CE-marked under MDR 2017/745). Smart Protocol also exists as a dedicated OEM-embedded variant certified for integration into Siemens Healthineers MRI consoles (first-ever CE-mark for embedded clinical AI in MRI from a major OEM). The platform targets hospitals, radiology centers, stroke centers, and teleradiology providers, and is available through direct deployment, OEM partnerships, and AI platform distributors (deepcOS, CARPL.ai).

Product and service1 record
1Apollo Software Suite
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-08-01
Description

Strategic OEM partnership with leading global MRI manufacturer. Cerebriu's Apollo Smart Protocol received CE-mark as the first-ever embedded clinical AI solution in MRI systems, integrated via SHS Open Workflow directly into Siemens Healthineers MRI scanner consoles. This landmark partnership enables deployment at scale through established medical imaging vendor channels.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-01
Description

Partnership with premier AI platform for medical imaging integration. Apollo Smart Reading integrated into deepcOS platform, enabling radiologists worldwide to access specialized brain MRI AI through seamless platform integration. deepc provides comprehensive radiology AI ecosystem with vendor-neutral validation and end-to-end integration.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

Integration with world's largest radiology AI marketplace. Smart Reading becomes accessible to CARPL.ai's global network of healthcare providers, combining CARPL.ai's orchestration platform with Cerebriu's workflow automation for intelligent brain MRI triage and prioritization.

4AXREM
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Membership in UK trade association for diagnostic imaging and radiotherapy. Active participation in AI Special Focus Group to shape future of AI in radiology and support responsible AI adoption in healthcare.

cerebriu.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-05-01
Description

Distribution partnership covering Switzerland and North Africa. HCK's extensive distribution network and market expertise increases availability of Cerebriu's AI-powered neuroimaging tools. HCK Hub platform routes anonymized patient data to AI platforms for accelerated processing.

6Copenhagen University Hospital
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Eurostars research partnership to develop AI software for stroke tissue window analysis. Cerebriu technology used to automatically identify patients eligible for thrombolysis/thrombectomy based on imaging, shifting from time-based to tissue-based stroke treatment assessment.

cerebriu.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Research collaboration with Computational Radiology and AI unit to clinically validate Cerebriu's novel stroke solution for real-time and instantaneous estimates of stroke onset and clinical outcomes after thrombectomy.

8Clalit Health Services
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership to automate radiology workflows with AI in Israeli healthcare system.

cerebriu.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership with Israeli medical center to implement AI-powered automation for radiology workflows.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-01
Description

Partnership to automate MRI exams combining Vista.ai's AI-guided software that automates MRI scanning with Cerebriu's Smart Protocol for right-first-time imaging. Joint solution showcased at RSNA 2024, moving toward autonomous MRI scanner vision.

Peers10 records
TypeDirect peer
Description

RapidAI is a leading AI platform for neurovascular and stroke imaging, offering real-time triage and workflow tools that compete directly with Cerebriu's Apollo in the brain MRI/stroke workflow category served to hospitals and stroke centers.

TypeDirect peer
Description

Viz.ai provides AI-powered care coordination and imaging triage for neurovascular conditions (notably stroke), competing head-to-head with Cerebriu's Smart Priority/Smart Reading modules in hospital stroke pathways.

TypeDirect peer
Description

Aidoc is a broad radiology AI platform that prioritizes urgent findings and integrates into hospital workflows. It overlaps with Cerebriu's worklist-prioritization and triage capabilities, serving the same enterprise radiology buyer.

TypeDirect peer
Description

icometrix specializes in AI for brain MRI quantification (notably multiple sclerosis and dementia), making it the closest anatomical peer to Cerebriu's brain-MRI focus and a potential competitor for hospital neurology imaging budgets.

TypeDirect peer
Description

Qure.ai offers FDA-cleared radiology AI across head CT, chest X-ray and other modalities, directly overlapping with Cerebriu's brain imaging AI category and global hospital distribution ambitions.

TypeEmerging player
Description

Annalise.ai provides comprehensive radiology AI for chest and head CT/MRI triage, competing for the same hospital radiology AI budget as Cerebriu but with a broader modality footprint.

TypeEmerging player
Description

Lunit develops medical imaging AI for cancer screening and triage (notably chest and mammography), representing an adjacent emerging competitor in the broader radiology AI workflow category Cerebriu addresses.

TypeBroad incumbent
Description

Siemens Healthineers is both Cerebriu's flagship OEM partner and a broad incumbent that ships its own AI-Rad Companion radiology AI suite. The dual role makes it both a critical channel and a potential competitor in embedded MRI AI.

TypeBroad incumbent
Description

GE HealthCare offers Edison AI platform and MRI systems, representing the broad incumbent that Cerebriu's sales team competes against in hospital imaging AI purchasing decisions.

TypeBroad incumbent
Description

Philips offers IntelliSpace AI and MRI scanners with embedded AI capabilities, positioning it as a broad incumbent competitor that Cerebriu must displace or partner with for hospital imaging AI deals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Key risks3 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds17 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cerebriu

Medical Imaging AI Softwarecerebriu.com

Cerebriu is a Danish health tech company developing Apollo, a CE-marked AI software suite for brain MRI workflow automation. It serves hospitals, radiology centers, and stroke centers across EMEA and APAC through OEM partnerships (Siemens Healthineers), AI platform distribution, and direct enterprise sales.

What Cerebriu does

Cerebriu is a Danish health technology company founded in 2018 that develops Apollo, a CE-marked AI software suite designed to automate brain MRI workflows from image acquisition through diagnosis. The platform comprises three integrated modules: Smart Priority (real-time scan monitoring that flags critical findings such as infarcts, hemorrhages, and tumors as they emerge during acquisition), Smart Protocol (real-time protocol adaptation that suggests or applies sequence modifications while the patient remains on the scanner table), and Smart Reading (AI-driven worklist prioritization and triage across multiple scanners and facilities). Cerebriu's AI was trained on multi-hospital datasets and validated in a 995-patient European Journal of Radiology study demonstrating 89% sensitivity and 90% specificity for acute ischemic lesion detection.

Apollo is regulated as a medical device in the EU under MDR 2017/745 Article 120 and achieved the first-ever CE-mark for embedded clinical AI integrated into MRI scanner consoles through a flagship OEM partnership with Siemens Healthineers via the SHS Open Workflow. The company runs its inference on Oracle Cloud Infrastructure GPU clusters, including NVIDIA GB200 NVL72 systems. Customers span hospitals, radiology centers, stroke centers, and teleradiology providers across Europe, Asia, the Middle East, and the US (clinical validation), including Copenhagen University Hospital, Oslo University Hospital, Clalit Health Services, Soroka Medical Center, Guy's and St Thomas' NHS Foundation Trust, UMC Utrecht, and Assuta Medical Centers.

Cerebriu monetizes through three revenue streams: OEM software licensing to MRI manufacturers (notably Siemens Healthineers), subscription-based access via AI platform partners (deepcOS, CARPL.ai), and direct enterprise sales through Regional Sales Managers covering EMEA and APAC territories. Distribution partnerships include HCKonnect for Switzerland and North Africa, and a co-development partnership with Vista.ai for automated MR acquisition. Total funding raised is approximately €26.8 million across a Eurostars grant (2021), a $19M Series A led by North Ventures (September 2024), and a €9.4M strategic financing round (August 2025). FDA clearance is in progress.

Cerebriu firmographics

Firmographics
Name
Cerebriu
Legal name
Cerebriu A/S
Website
https://cerebriu.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Cerebriu is a Danish health tech company developing Apollo, a CE-marked AI software suite for brain MRI workflow automation. It serves hospitals, radiology centers, and stroke centers across EMEA and APAC through OEM partnerships (Siemens Healthineers), AI platform distribution, and direct enterprise sales.
Ownership category
akta.pro rank

Cerebriu industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • AI medical imaging
  • Brain MRI workflow
  • Radiology AI software
  • MRI protocol optimization
  • Medical imaging analytics

Where Cerebriu is headquartered

Location

Headquarters

HQ city
Copenhagen
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

Cerebriu business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. OEM Software Licensing: Cerebriu licenses its Apollo Software Suite to OEM partners like Siemens Healthineers for integration into MRI scanner consoles. The software is embedded at point of manufacture, generating recurring licensing revenue from OEM deployment.
  2. Platform Subscription: AI platform and distributor partnerships (deepc, CARPL.ai) provide subscription-based access to Apollo modules. Healthcare providers access Smart Reading and other features through integrated platforms, creating recurring SaaS-type revenue.
  3. Direct Enterprise Sales: Direct B2B sales of Apollo platform to hospitals, diagnostic groups, and imaging networks. Sales cycles involve clinical and executive stakeholder engagement with Regional Sales Managers covering EMEA and APAC territories.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise pricing based on deployment scope
Licensing/ royaltiesMulti-year contractOEM/Embedded deployment pricing

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

Cerebriu product offering

Product offering

Core offering

Cerebriu develops Apollo, a CE-marked AI-powered Software Suite for brain MRI workflows. Apollo operates at the point of imaging to optimize the end-to-end brain MRI pathway from acquisition to diagnosis through three integrated modules: Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation while patient remains on scanner), and Smart Reading (AI-driven worklist prioritization and triage). The suite is sold to hospitals, radiology centers, and OEMs, including a dedicated OEM-embedded variant integrated into Siemens Healthineers MRI consoles.

Product overview

Cerebriu offers Apollo, an AI-powered Software Suite for brain MRI workflows. Apollo is a modular platform comprising three core AI modules — Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation), and Smart Reading (AI-driven worklist prioritization and triage) — that collectively automate the end-to-end brain MRI pathway from image acquisition through diagnosis. Apollo is regulated as a medical device in the EU (CE-marked under MDR 2017/745). Smart Protocol also exists as a dedicated OEM-embedded variant certified for integration into Siemens Healthineers MRI consoles (first-ever CE-mark for embedded clinical AI in MRI from a major OEM). The platform targets hospitals, radiology centers, stroke centers, and teleradiology providers, and is available through direct deployment, OEM partnerships, and AI platform distributors (deepcOS, CARPL.ai).

Differentiator

Problem solved

Functional benefit

Brands

  • Apollo: AI-based Software Suite for brain MRI workflow optimization providing real-time alerts on critical conditions, on-table detection of critical findings for prioritized reading, and real-time adaptation of MR scanning protocols.

Products and services

  • Apollo Software Suite

Quantifiable outcome

  • 89% sensitivity and 90% specificity for acute ischemic lesion detection on brain MRI
  • +4 more outcomes

Companies that use Cerebriu

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Cerebriu technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature4 records

Cerebriu partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

  • Siemens HealthineersflagshipOEM/ Whitelabel/ Licensing Partner · 1 August 2025Strategic OEM partnership with leading global MRI manufacturer. Cerebriu's Apollo Smart Protocol received CE-mark as the first-ever embedded clinical AI solution in MRI systems, integrated via SHS Open Workflow directly into Siemens Healthineers MRI scanner consoles. This landmark partnership enables deployment at scale through established medical imaging vendor channels.
  • deepccoreTechnology or Integration · 1 February 2025Partnership with premier AI platform for medical imaging integration. Apollo Smart Reading integrated into deepcOS platform, enabling radiologists worldwide to access specialized brain MRI AI through seamless platform integration. deepc provides comprehensive radiology AI ecosystem with vendor-neutral validation and end-to-end integration.
  • CARPL.aicoreTechnology or Integration · 1 January 2025Integration with world's largest radiology AI marketplace. Smart Reading becomes accessible to CARPL.ai's global network of healthcare providers, combining CARPL.ai's orchestration platform with Cerebriu's workflow automation for intelligent brain MRI triage and prioritization.
  • AXREMminorGTM or Marketing Partner · 1 January 2025Membership in UK trade association for diagnostic imaging and radiotherapy. Active participation in AI Special Focus Group to shape future of AI in radiology and support responsible AI adoption in healthcare.
  • HCKonnect (HCK)coreChannel Partner/ Reseller/ Distributor · 1 May 2024Distribution partnership covering Switzerland and North Africa. HCK's extensive distribution network and market expertise increases availability of Cerebriu's AI-powered neuroimaging tools. HCK Hub platform routes anonymized patient data to AI platforms for accelerated processing.
  • Copenhagen University HospitalcoreStrategic or Co-development Partner · 1 January 2024Eurostars research partnership to develop AI software for stroke tissue window analysis. Cerebriu technology used to automatically identify patients eligible for thrombolysis/thrombectomy based on imaging, shifting from time-based to tissue-based stroke treatment assessment.
  • Oslo University HospitalcoreStrategic or Co-development Partner · 1 January 2024Research collaboration with Computational Radiology and AI unit to clinically validate Cerebriu's novel stroke solution for real-time and instantaneous estimates of stroke onset and clinical outcomes after thrombectomy.
  • Clalit Health ServicesminorStrategic or Co-development Partner · 1 January 2024Partnership to automate radiology workflows with AI in Israeli healthcare system.
  • Soroka Medical CenterminorStrategic or Co-development Partner · 1 January 2024Partnership with Israeli medical center to implement AI-powered automation for radiology workflows.
  • Vista.aicoreStrategic or Co-development Partner · 1 November 2023Partnership to automate MRI exams combining Vista.ai's AI-guided software that automates MRI scanning with Cerebriu's Smart Protocol for right-first-time imaging. Joint solution showcased at RSNA 2024, moving toward autonomous MRI scanner vision.

Scale indicators6 records

Cerebriu competitors and assessment

Company assessment

Direct peers

  • RapidAI: RapidAI is a leading AI platform for neurovascular and stroke imaging, offering real-time triage and workflow tools that compete directly with Cerebriu's Apollo in the brain MRI/stroke workflow category served to hospitals and stroke centers.
  • Viz.ai: Viz.ai provides AI-powered care coordination and imaging triage for neurovascular conditions (notably stroke), competing head-to-head with Cerebriu's Smart Priority/Smart Reading modules in hospital stroke pathways.
  • Aidoc: Aidoc is a broad radiology AI platform that prioritizes urgent findings and integrates into hospital workflows. It overlaps with Cerebriu's worklist-prioritization and triage capabilities, serving the same enterprise radiology buyer.
  • icometrix: icometrix specializes in AI for brain MRI quantification (notably multiple sclerosis and dementia), making it the closest anatomical peer to Cerebriu's brain-MRI focus and a potential competitor for hospital neurology imaging budgets.
  • Qure.ai: Qure.ai offers FDA-cleared radiology AI across head CT, chest X-ray and other modalities, directly overlapping with Cerebriu's brain imaging AI category and global hospital distribution ambitions.

Emerging players

  • Annalise.ai: Annalise.ai provides comprehensive radiology AI for chest and head CT/MRI triage, competing for the same hospital radiology AI budget as Cerebriu but with a broader modality footprint.
  • Lunit: Lunit develops medical imaging AI for cancer screening and triage (notably chest and mammography), representing an adjacent emerging competitor in the broader radiology AI workflow category Cerebriu addresses.

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers is both Cerebriu's flagship OEM partner and a broad incumbent that ships its own AI-Rad Companion radiology AI suite. The dual role makes it both a critical channel and a potential competitor in embedded MRI AI.
  • GE HealthCare: GE HealthCare offers Edison AI platform and MRI systems, representing the broad incumbent that Cerebriu's sales team competes against in hospital imaging AI purchasing decisions.
  • Philips (IntelliSpace AI): Philips offers IntelliSpace AI and MRI scanners with embedded AI capabilities, positioning it as a broad incumbent competitor that Cerebriu must displace or partner with for hospital imaging AI deals.

Market position

Strengths5 records

Weaknesses5 records

Key risks3 records

Key highlights6 records

Customer concentration

Cerebriu social profiles

Digital presence

Cerebriu compliance and trust

Trust signal

Compliance2 records

Cerebriu financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cerebriu leadership team

Management profile

Number of profiles

Profiles9 records

Cerebriu funding detail

Funding detail

Funding overview

Funding rounds17 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cerebriu M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cerebriu

What does Cerebriu do?

Cerebriu develops Apollo, a CE-marked AI-powered Software Suite for brain MRI workflows. Apollo operates at the point of imaging to optimize the end-to-end brain MRI pathway from acquisition to diagnosis through three integrated modules: Smart Priority (real-time scan monitoring and critical finding alerts), Smart Protocol (real-time protocol adaptation while patient remains on scanner), and Smart Reading (AI-driven worklist prioritization and triage). The suite is sold to hospitals, radiology centers, and OEMs, including a dedicated OEM-embedded variant integrated into Siemens Healthineers MRI consoles.

Is Cerebriu a public or private company?

Cerebriu is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cerebriu founded?

Cerebriu was founded in 2018. It employs 51 to 100 people.

Where is Cerebriu based?

Cerebriu is headquartered in Copenhagen, Denmark, in the Europe region.

How does Cerebriu make money?

Three revenue lines are on record. OEM Software Licensing is the primary driver. The others are platform Subscription and direct Enterprise Sales.

Who are Cerebriu's main competitors?

Direct peers on record are RapidAI, Viz.ai, Aidoc, icometrix and Qure.ai. Emerging players are Annalise.ai and Lunit. Broad incumbents are Siemens Healthineers, GE HealthCare and Philips (IntelliSpace AI).

Does Cerebriu have an API?

No public API is recorded for Cerebriu.

What industry is Cerebriu in?

Cerebriu's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TheimagingwireVC Funding Bounces Back in 2025Venture capital funding for medical imaging AI companies rebounded significantly in 2025, with total funding more than doubling to $709 million from $336 million the prior year, according to Signify Research. While the number of funding rounds fell 17% to 19, the average funding round size grew 112% to $39 million, reflecting increased investor selectivity toward companies with clear enterprise fit and platform integration capabilities. Notable 2025 funding rounds included Aidoc's $150 million raise, Ultromics joining the $100 million club, Cerebriu's $10 million Series A, and a2z's $4.5 million seed round.LinkedInAI in Medical Imaging - September Round-upBayer announced its exit from the radiology AI platform market, discontinuing its Calantic Digital Solutions platform and winding down services from subsidiary Blackford Analysis, which had hosted over 150 third-party applications from 60 vendors. The month saw significant market consolidation with three acquisitions (GE HealthCare acquiring icometrix, Lunit Cancer Screening acquiring Prognosia, and VUNO Inc. selling its BoneAge business to maihub Corp.), alongside multiple funding rounds including Cerebriu's €9.4m round and Artrya's A$80m equity offering. An analysis of Medicare claims between 2018-2023 found that over half of the 93,392 submitted claims for AI were denied, with $16m in claims rejected versus $8m approved, highlighting the gap between regulatory clearance and reimbursement for radiology AI vendors.AxremCerebriu Secures CE-Mark for First OEM-Embedded AI Product with Siemens Healthineers and Raises €9.4M to Scale MRI Automation GloballyCerebriu, a Copenhagen-based AI company focused on MRI technology, announced the CE-marking of its Apollo Smart Protocol as an OEM-embedded solution within Siemens Healthineers MRI consoles, marking the first-ever clearance for embedded clinical AI in MRI systems from a leading global manufacturer. The company simultaneously closed a €9.4 million strategic financing round led by North Ventures and Sagitta, bringing its total funding to €26.8 million. With regulatory approval secured and the funding in place, Cerebriu is now scaling its Apollo Suite across Europe, the US, Asia, and the Middle East while pursuing FDA clearance.Imaging Technology NewsCerebriu Secures CE Mark for First OEM-Embedded AI Product with Siemens HealthineersCerebriu announced it received the CE mark for its Apollo Smart Protocol as an OEM-embedded solution in Siemens Healthineers MRI consoles, marking the first regulatory clearance for embedded clinical AI in MRI systems from a leading manufacturer. This milestone is expected to facilitate the global deployment of intelligent MRI technology and implies a significant advancement in radiology by enabling real-time adaptation of imaging protocols during scans. Cerebriu is also pursuing FDA clearance as it scales its solutions across multiple regions including Europe, the U.S., Asia, and the Middle East.CerebriuCerebriu Secures CE-Mark for First OEM-Embedded AI Product with Siemens Healthineers and Raises €9.4M to Scale MRI Automation GloballyCerebriu secured CE-marking for its Apollo Smart Protocol as an OEM-embedded AI solution in Siemens Healthineers MRI consoles, and raised €9.4 million in a financing round led by North Ventures. The funding brings total investment to €26.8 million and enables global deployment of intelligent MRI, with FDA clearance underway.DeepcCerebriu and deepc Partner to Enhance AI-Powered Brain MRI Detection and Workflow OptimizationCerebriu and deepc have partnered to integrate Cerebriu's Apollo Smart Reading AI solution into the deepcOS platform, enabling radiologists worldwide to detect critical brain MRI findings. This collaboration allows for the automated prioritization of urgent cases such as strokes and tumors directly through RIS systems to streamline workflows. The move expands deepc's suite of regulatory-approved AI solutions while making specialized brain MRI detection tools more accessible to healthcare providers.Health-HollandArtificial intelligence-augmented contrast enhancement production in brain MRIDanish start-up Cerebriu and Amsterdam UMC Radiology department are collaborating to develop Apollo SmartGAD, an AI software tool that generates synthetically contrast-enhanced brain MRI images from non-contrast or low-contrast scans. This innovation aims to reduce patient exposure to gadolinium-based agents, shorten scan times significantly through the use of MR Stat sequences, and lower healthcare costs.OresundstartupsCerebriu Secures €17.4M to Expand AI-Powered MRI Solutions GloballyCopenhagen-based Cerebriu secured €17.4 million in a Series A funding round led by North Ventures to expand its AI-powered MRI workflow software, Apollo, globally. The investment aims to address rising demand for MRI exams amid global radiologist shortages and will support partnerships with Siemens Healthineers and US hospitals for further clinical validation.CerebriuRadiology AI firm specializing in automating MRI workflows raises $19MCerebriu, an AI-powered radiology firm, raised $19 million in a Series A funding round to enhance MRI accessibility through its technology. The funding comes from North Ventures, along with support from EIFO and Sagitta Ventures, allowing Cerebriu to expand its portfolio and accelerate its commercial development. This investment aims to address staffing shortages in radiology departments worldwide as the demand for MRI exams continues to increase.